1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
"Kansas 988 Operational Grant" is currently closed and not accepting applications.
Kansas 988 Operational Grant is sponsored by Kansas Department for Aging and Disability Services (KDADS) (administered by Sedgwick County COMCARE). This state-funded grant supports activities and responsibilities necessary to accomplish suicide prevention goals and objectives across the lifespan. Nonprofits involved in suicide prevention and crisis services in Kansas could be eligible.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Programs supporting suicide prevention goals and objectives across the lifespan in Kansas. Confirm the full requirements in the official notice before applying.
The current listing shows $1,048,893.00. Verify award ceilings, matching requirements, and allowable costs in the official notice.
The published deadline was June 30, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
Kansas 988 Operational Grant is funded by Kansas Department for Aging and Disability Services (KDADS) (administered by Sedgwick County COMCARE). Verify program details on the funder's official page before applying.
This opportunity targets applicants in Kansas. If your organization operates elsewhere, check the official notice for location requirements.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
Seven research teams will run the first clinical trials aimed at extending human healthspan under ARPA-H PROSPR contracts worth up to $144M. The milestone-based contract model breaks every convention of federal biomedical funding.
Read articleARPA-H PROSPR program funds seven research teams up to $144M to develop the first clinical trials targeting biological aging itself, testing rapamycin analogs, semaglutide, and retrotransposon inhibitors.
Read articleARPA-H awarded $144M across 7 research teams to run the first clinical trials treating aging as a condition — not a disease. How PROSPR reshapes longevity funding and what grant seekers in biotech, academia, and health tech should know.
Read article